Vancouver-based Bioasis Technologies has opened an office in Guilford, CT.

“Establishing a strong presence in the U.S. is an important next step in the evolution of Bioasis,” said Mark Day, Ph.D., president and chief executive officer.

Bioasis focuses on the delivery of therapeutics across the blood-brain barrier and into the central nervous system for the treatment of neurological diseases and disorders.

press release
Bioasis website